Prelude Therapeutics (PRLD) Shareholder's Equity Growth (1y) (2020 - 2026)
Prelude Therapeutics (PRLD) Shareholder's Equity Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Prelude Therapeutics |
358.14 Mn |
213.54 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-41.67% |
| Dec 31, 2025 |
-47.79% |
| Sep 30, 2025 |
-62.58% |
| Jun 30, 2025 |
-58.39% |
| Mar 31, 2025 |
-51.04% |
| Dec 31, 2024 |
-44.55% |
| Sep 30, 2024 |
-34.34% |
| Jun 30, 2024 |
-30.44% |
| Mar 31, 2024 |
20.22% |
| Dec 31, 2023 |
21.31% |
| Sep 30, 2023 |
9.59% |
| Jun 30, 2023 |
8.81% |
| Mar 31, 2023 |
-33.04% |
| Dec 31, 2022 |
-31.64% |
| Sep 30, 2022 |
-30.15% |
| Jun 30, 2022 |
-27.97% |
| Mar 31, 2022 |
-26.57% |
| Dec 31, 2021 |
34.74% |
| Sep 30, 2021 |
36.33% |
| Jun 30, 2021 |
582.41% |
